Clinical Trials Directory

Trials / Recruiting

RecruitingNCT01084967

Genetics of Obesity in Chinese Youngs

Study of Clinical Characteristics and Genetic Susceptibility in Chinese Obese Youngs

Status
Recruiting
Phase
Study type
Observational
Enrollment
8,000 (estimated)
Sponsor
Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
14 Years – 30 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to explore the pathogenesis and genetic susceptibility of obese subjects,providing a convincing argument for further treatment of obesity and metabolic syndrome.

Detailed description

Obesity has become a major worldwide challenge to public health, owing to an interaction between the obesogenic environment and a strong genetic contribution.Previous studies found that genetic factors determine 40%-70% of obese phenotype.Under such circumstances, the screening of obesity susceptibility gene is particularly important for society or family to take measures to prevent obesity. Recent extensive genome-wide association studies(GWASs) have identified numerous single nucleotide polymorphisms associated with obesity,but these loci together account for only a small fraction of the known heritable component.Two studies in 2010 Nature,for the first time, put rare copy number variation (CNV)in association with severe early-onset obesity.Their significance lie not only in the discovery of the pathogenic genes of severe early-onset obesity but,more importantly,in providing new strategies for finding out genes that cause complex diseases. Obese patients and healthy lean controls proved by a series of blood biochemical examinations will be enrolled in this study.The present study intends to use the techniques such as enzyme-linked immunosorbent assay, real-time fluorescence quantitative PCR,gene chip,construction of viral vectors,transfection, taking advantage of the established database,by means of serum assays and functional tests, associate copy number variation with obesity phenotype to explain the root cause of obesity.Meanwhile biomarkers, gut flora and genetic risk factors will be evaluated in the study subjects.

Conditions

Timeline

Start date
2009-03-01
Primary completion
2026-04-01
Completion
2026-04-01
First posted
2010-03-11
Last updated
2021-04-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01084967. Inclusion in this directory is not an endorsement.